LAKE OSWEGO, Ore., May 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Rosemary Mazanet, M.D., Ph.D., Executive Vice President & Chief Medical Officer will present a corporate update at the 2013 Marcum MicroCap Conference. The presentation will take place on Thursday, May 30, 2013 at 2:00 p.m. ET at The Grand Hyatt Hotel in New York, NY.
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .
CONTACT: Remy Bernarda Senior Director, Communications (503) 405-8258 email@example.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts